Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bear bile pill in Major Depressive Disorder
NCT04509882Phase 2Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Oct 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xiongdan wan in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
xiongdan wan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04509882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509882.